Search results for "Trie"

showing 10 items of 4468 documents

Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000-17: analysis for th…

2020

Background: Across low-income and middle-income countries (LMICs), one in ten deaths in children younger than 5 years is attributable to diarrhoea. The substantial between-country variation in both diarrhoea incidence and mortality is attributable to interventions that protect children, prevent infection, and treat disease. Identifying subnational regions with the highest burden and mapping associated risk factors can aid in reducing preventable childhood diarrhoea. Methods: We used Bayesian model-based geostatistics and a geolocated dataset comprising 15 072 746 children younger than 5 years from 466 surveys in 94 LMICs, in combination with findings of the Global Burden of Diseases, Injuri…

Low income countriesmedicine.medical_treatment030204 cardiovascular system & hematologyGlobal HealthTHERAPYGlobal Burden of Disease0302 clinical medicinePrevalenceGlobal healthMedicineWATER030212 general & internal medicineChildren11 Medical and Health SciencesIncidenceMortality rateIncidence (epidemiology)1. No povertyGeneral Medicine3142 Public health care science environmental and occupational healthDiarrhoea3. Good healthChild PreschoolMiddle income countriesA990 Medicine and Dentistry not elsewhere classifiedTERRITORIESLife Sciences & BiomedicineInfantsDiarrheaAFRICAmedicine.medical_specialtyChildhood deathsRJsanitationDeveloping countryChildhood diarrhoeal morbidityITC-HYBRID03 medical and health sciencesMedicine General & InternalGeneral & Internal MedicineEnvironmental healthSYSTEMATIC ANALYSISLife ScienceHumansHealthcare DisparitiesOral rehydration therapyRisk factorhand washingDeveloping CountriesDisease burdenGlobal NutritionWereldvoedingScience & TechnologySEX-SPECIFIC MORTALITYbusiness.industryCHOLERAPublic healthBayes Theoremdiarrheal diseaseLocal Burden of Disease Diarrhoea CollaboratorsITC-ISI-JOURNAL-ARTICLENAHuman medicineDiarreabusiness
researchProduct

Backing out of private pension provision - Lessons from Germany

2012

Financing pensions in the EU is a challenge. Many EU countries introduced private pension schemes to compensate declining public pension levels due to reforms made necessary by demographic change. In 2001, Germany introduced the Riester pension. Ten years after introduction the prevalence rate of this voluntary private pension scheme approximates 37 %. However, numerous criticisms raise doubts that the market for Riester products is transparent. Using the 2010 German SAVE survey, this article investigates terminated and dormant Riester contracts on a household level for the first time. Respectively 14.5 and 12.5 % of households who own or have owned a Riester contract terminated or set dorm…

Low incomeEndowment policyjel:D91Labour economicsPensionprivate pension Riester termination financial literacy SAVEPovertyGeography Planning and DevelopmentPrivate pensionjel:D12DevelopmentEu countriesjel:D14TurnoverFinancial wealthEuropean integrationjel:J26EconomicsFinancial literacyBusinesshealth care economics and organizationsPublic finance
researchProduct

Low-risk isn’t no-risk: Perinatal treatments and the health of low-income newborns

2019

We investigate the effects of perinatal medical treatments on low-income newborns who are classified as low-risk. A policy rule in The Netherlands states that low-risk deliveries before week 37 should be supervised by physicians and later deliveries only by midwives with no physician present. This creates large discontinuities in the probability of receiving medical interventions only physicians are allowed to perform. Using a regression discontinuity design, we find that babies born slightly before the week-37 cutoff are significantly less likely to die than babies born slightly later. Our data suggest that physician supervision of birth reduces the likelihood of adverse events such as fet…

Low incomemedicine.medical_specialtyPerinatal carePsychological interventionPerinatal careGestational AgeRisk AssessmentMedical careMidwivesMedical interventions03 medical and health sciencesMedical treatmentsPregnancy0502 economics and businessFetal distressmedicineHumansRegistriesMortality050207 economicsAdverse effectPovertyNetherlandsQuality of Health CareObstetricsbusiness.industry030503 health policy & servicesHealth Policy05 social sciencesInfant NewbornParturitionPublic Health Environmental and Occupational Healthmedicine.diseasePerinatal CareBirthRegression discontinuity designFemalePrematurity0305 other medical sciencebusinessJournal of Health Economics
researchProduct

C,N-chelated diaminocarbene platinum(II) complexes derived from 3,4-diaryl-1H-pyrrol-2,5-diimines and cis-dichlorobis(isonitrile)platinum(II): Synthe…

2020

The reaction of 3,4-diaryl-1H-pyrrol-2,5-diimines with cis-dichlorobis(isonitrile)platinum(II) affords the C,N-chelated diaminocarbene platinum(II) complexes, which have been fully characterized including molecular spectroscopy, single crystal X-ray diffraction and DFT calculations. The obtained platinum(II) complexes are effective catalysts for the hydrosilylation of alkynes and alkenes. Thus, the reaction of phenylacetylene with triethoxysilane leads to the formation of α- and β-(E)-vinylsilanes, generating TON's in the range of 103 to 104 and TOF's in the range of 102 to 103 h−1. Also, the cross-linked silicones, possessing the luminescence properties, were obtained by the hydrosilylatio…

LuminescenceHydrosilylationchemistry.chemical_element010402 general chemistry01 natural sciencesBiochemistryCatalysisCatalysisInorganic Chemistrychemistry.chemical_compoundAnti-cancer activityPolymer chemistryluminescenceMaterials ChemistryChelationPhysical and Theoretical Chemistrydiaminocarbene platinum(II) complexescatalysis010405 organic chemistryOrganic Chemistryhydrosilylation0104 chemical scienceschemistryPhenylacetyleneDiaminocarbene platinum(II) complexesHydrosilylationTriethoxysilaneanti-cancer activityLuminescencePlatinumSingle crystalJournal of Organometallic Chemistry
researchProduct

Mast cells and the development of allergic airway disease

2008

Murine models have highlighted the importance of T-cells and TH2 cytokines in development of allergen-induced airway disease. In contrast, the role of mast cells for the development of allergic airway disease has been controversial. Recent studies in murine models demonstrate a significant contribution of mast cells during the development of airway hyperresponsiveness and airway inflammation. Furthermore these models have allowed identifying certain mast cell-produced mediators (e.g. histamine and leukotriene B4) to be involved in the recruitment of effector T-cells into the lung. Additionally, mast cell-produced TNF can directly activate TH2 cells and contribute to the development of aller…

Lungbusiness.industryLeukotriene B4EffectorAirway inflammationPublic Health Environmental and Occupational HealthReviewrespiratory systemToxicologyrespiratory tract diseaseschemistry.chemical_compoundmedicine.anatomical_structureAirway diseasechemistryImmunologymedicineTumor necrosis factor alphabusinessSafety ResearchSensitizationHistamineJournal of Occupational Medicine and Toxicology
researchProduct

L'accès à la formation professionnelle dans trois secteurs de l'économie européenne

1993

CEDEFOP; série panorama, analyse comparéeRéférence interne : 93035

Luxembourg[SHS.EDU]Humanities and Social Sciences/Education[SHS.EDU] Humanities and Social Sciences/EducationAnalyse sectorielle[ SHS.ECO ] Humanities and Social Sciences/Economies and financesFormation professionnelleAccès à la formation[SHS.ECO] Humanities and Social Sciences/Economics and FinanceIndustrie électrique électroniqueDanemarkItalieBelgiquePortugalEspagneSecteur de la constructionFormation professionnelle continueAllemagne[ SHS.EDU ] Humanities and Social Sciences/EducationIrlandePays-Bas[SHS.ECO]Humanities and Social Sciences/Economics and FinanceÉconomieSecteur tertiaireEuropePratique de formationFranceRoyaume-UniGrèce
researchProduct

Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies

2020

AbstractThere are large between- and within-country variations in COVID-19 death rates. Some very low death rate settings such as Eastern Asia, Central Europe, the Balkans and Africa have a common feature of eating large quantities of fermented foods whose intake is associated with the activation of the Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) anti-oxidant transcription factor. There are many Nrf2-interacting nutrients (berberine, curcumin, epigallocatechin gallate, genistein, quercetin, resveratrol, sulforaphane) that all act similarly to reduce insulin resistance, endothelial damage, lung injury and cytokine storm. They also act on the same mechanisms (mTOR: Mammalian target of …

MAPK/ERK pathwayARIA groupAllergy[SDV]Life Sciences [q-bio]NF-KAPPA-BdebelostReviewPharmacologyResveratrolPROTECTSchemistry.chemical_compound0302 clinical medicineRESPIRATORY SYNDROME CORONAVIRUSENDOPLASMIC-RETICULUM STRESSMedicine and Health SciencesImmunology and AllergyMedicineOXIDATIVE STRESSCOVID-19; Foods; Insulin resistance; Nrf2; Nutrients; Obesity; TRPA12. Zero hunger0303 health sciencesRESPIRATORYINSULIN-RESISTANCEMuscle cell proliferationSULFORAPHANE3. Good health[SDV] Life Sciences [q-bio]Foods030220 oncology & carcinogenesisSIGNALING PATHWAYSignal transductionLife Sciences & BiomedicinePulmonary and Respiratory MedicineNRF2 ACTIVATORSMUSCLE-CELL PROLIFERATIONImmunology610 Medicine & healthLung injurySettore MED/10 - Malattie Dell'Apparato RespiratorioTRPA1Nrf2ACUTE LUNG INJURY03 medical and health sciencesInsulin resistanceCOVID-19 Foods Insulin resistance Nrf2 Nutrients Obesity TRPA1udc:616.9odpornost proti inzulinuSULFORAPHANE PROTECTSObesityTranscription factorPI3K/AKT/mTOR pathway030304 developmental biologyScience & Technologybusiness.industrySARS-CoV-2foodCOVID-19Insulin resistanceNutrientsmedicine.diseasechemistryhranilaSYNDROME CORONAVIRUSbusinesshranaGREEN TEA
researchProduct

Removal of carbon and nutrients from wastewater in a moving bed membrane biofilm reactor: the influence of the sludge retention time

2016

A University of Cape Town (UCT) pilot plant combining both membrane bioreactor (MBR) and moving bed biofilm reactor (MBBR) technology was monitored. Three experimental Phases were carried out by varying the mixed liquor sludge retention time (SRT) (indefinite, 30 and 15 days, respectively). The system performance has been investigated during experiments in terms of: organic carbon, nitrogen and phosphorus removal, biokinetic/stoichiometric constants, membrane fouling tendency and sludge dewaterability. The observed results showed that by decreasing the SRT the UCT pilot plant was able to maintain very high total COD removal efficiencies, whilst the biological COD removal efficiency showed a…

MBRnutrients removalSettore ICAR/03 - Ingegneria Sanitaria-Ambientalemembrane foulingMBBRUCTUCT; MBBR; nutrients removal; MBR; membrane fouling
researchProduct

Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.

2016

IF 10.383; International audience; OBJECTIVES: Cancer may be a complication of inflammatory bowel disease (IBD) or its treatment. In elderly onset IBD patients the risk of malignancy is of particular concern. We studied this risk in a population-based cohort of elderly onset IBD patients.METHODS: In a French population-based cohort, we identified 844 patients aged >60 years at IBD diagnosis from 1988 to 2006, including 370 Crohn's disease (CD) and 474 ulcerative colitis (UC). We compared incidence of cancer among IBD patients with that observed in the French Network of population-based Cancer Registries (FRANCIM). Confidence interval (CI) was estimated assuming a Poisson-specific law for ra…

MESH: CarcinomaMaleNonmelanoma Skin-CancerInflammatory bowel disease0302 clinical medicineAdrenal Cortex HormonesAzathioprineMESH: IncidenceAge of OnsetAged 80 and overeducation.field_of_studyMESH: Middle AgedRheumatoid-ArthritisIncidenceGastroenterologyMESH: Follow-Up StudiesMESH: Anti-Inflammatory Agents Non-Steroidal3. Good health030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatology[ SDV.MHEP.HEG ] Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyMESH: Immunosuppressive Agentsmedicine.medical_specialtyMESH: Age of OnsetMESH: Colitis Ulcerativedigestive systemMESH: Adrenal Cortex Hormones03 medical and health sciencesIntestinal NeoplasmsHumansCrohns-DiseaseeducationMESH: Intestinal NeoplasmsMESH: Protective FactorsMESH: AzathioprineAgedRetrospective StudiesMESH: HumansMESH: Crohn DiseaseTumor Necrosis Factor-alphaMESH: Retrospective Studiesmedicine.diseaseMESH: Inflammatory Bowel DiseasesInflammatory Bowel Diseasesdigestive system diseasesLymphoproliferative DisordersMethotrexateMESH: Tumor Necrosis Factor-alphaColitis UlcerativeComplicationMESH: FemaleProspective Observational CohortTime FactorsMESH: RegistriesMESH: Proportional Hazards ModelsMaintenance TherapyMESH: Aged 80 and overMESH: Lymphoproliferative DisordersCrohn DiseaseMESH: Risk FactorsRisk FactorsNeoplasmsMESH: NeoplasmsRegistriesUlcerative-ColitisMesalamineMESH: AgedIncidence (epidemiology)Anti-Inflammatory Agents Non-SteroidalMetaanalysisMiddle AgedhumanitiesMESH: MethotrexateFemaleFranceFrench PopulationColorectal NeoplasmsImmunosuppressive AgentsMESH: Myeloproliferative DisordersPopulationColorectal-CancerIncreased RiskInternal medicinemedicineProportional Hazards ModelsMyeloproliferative DisordersHepatologybusiness.industryMESH: Time FactorsCarcinomaCancerRetrospective cohort study[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyMESH: MesalamineProtective FactorsMESH: MaleMESH: FranceAge of onsetbusinessMESH: Colorectal NeoplasmsFollow-Up StudiesThe American journal of gastroenterology
researchProduct

Real Algebraic Geometry

2011

144 Pages; Cet ouvrage constitue les actes de la conférence de Géométrie Algébrique Réelle qui a eu lieu à Rennes du 20 au 24 Juin 2011

MSC 14Pxx[MATH.MATH-AG] Mathematics [math]/Algebraic Geometry [math.AG]GéométrieRéelleAlgébrique[MATH.MATH-AG]Mathematics [math]/Algebraic Geometry [math.AG]ComputingMilieux_MISCELLANEOUS[ MATH.MATH-AG ] Mathematics [math]/Algebraic Geometry [math.AG]
researchProduct